About: Coronavirus Disease 2019: Coronaviruses and Blood Safety

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Coronavirus Disease 2019: Coronaviruses and Blood Safety Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Coronavirus Disease 2019: Coronaviruses and Blood Safety
Creator	Yan, Ying Wang, Lunan Chang, Le
Source	Elsevier; Medline; PMC; WHO
abstract	Abstract With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The World Health Organization declared COVID-19 in China as a Public Health Emergency of International Concern. Two other coronavirus infections—SARS in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012—both caused severe respiratory syndrome in humans. All 3 of these emerging infectious diseases leading to a global spread are caused by β-coronaviruses. Although coronaviruses usually infect the upper or lower respiratory tract, viral shedding in plasma or serum is common. Therefore, there is still a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products. Because more and more asymptomatic infections are being found among COVID-19 cases, considerations of blood safety and coronaviruses have arisen especially in endemic areas. In this review, we detail current evidence and understanding of the transmission of SARS-CoV, MERS–CoV, and SARS-CoV-2 through blood products as of February 10, 2020, and also discuss pathogen inactivation methods on coronaviruses.
has issue date	2020-02-21(xsd:dateTime)
bibo:doi	10.1016/j.tmrv.2020.02.003
bibo:pmid	32107119
has license	els-covid
sha1sum (hex)	a9a4101b25236a4fc0e14a9cbdd904ca8b2baffd
schema:url	https://doi.org/10.1016/j.tmrv.2020.02.003
resource representing a document's title	Coronavirus Disease 2019: Coronaviruses and Blood Safety
has PubMed Central identifier	PMC7135848
has PubMed identifier	32107119
schema:publication	Transfus Med Rev
resource representing a document's body	covid:a9a4101b25236a4fc0e14a9cbdd904ca8b2baffd#body_text
is schema:about of	named entity 'CORONAVIRUS DISEASE 2019' named entity 'BLOOD SAFETY' named entity 'CORONAVIRUSES' named entity 'Blood' named entity 'Safety' named entity 'fever' named entity 'SARS-CoV' named entity 'viral RNA' named entity 'virus' named entity 'SARS-CoV-2' named entity 'pneumonia' named entity 'SARS' named entity 'plasma' named entity 'transfusion' named entity 'riboflavin' named entity '2019-nCoV' named entity '21 days' named entity 'plasma' named entity 'DMEM' named entity 'viremia' named entity 'coronaviruses' named entity 'respiratory illness' named entity 'peripheral blood stem cells' named entity 'SARS-CoV' named entity 'infection' named entity 'epithelial cells' named entity 'respiratory disease' named entity 'Plasma' named entity 'virus' named entity 'Germany' named entity 'Germany' named entity 'RNA' named entity 'antibody' named entity 'Hubei' named entity 'asymptomatic infections' named entity 'blood banks' named entity 'MERS' named entity 'HCoV-229E' named entity 'plasma' named entity 'RNA' named entity 'Middle East' named entity 'China' named entity 'Hubei' named entity 'United States' named entity '95% CI' named entity 'plasma' named entity 'transfusion' named entity 'virus' named entity 'Tween 80' named entity 'SARS' named entity 'viral load' named entity 'virus' named entity 'fever' named entity 'SARS virus' named entity 'SARS-CoV-2' named entity 'bovine serum albumin' named entity 'virus' named entity 'fever' named entity 'blood donation' named entity 'virus' named entity 'virus' named entity 'next-generation sequencing' named entity 'SARS-CoV-2' named entity 'blood donors' named entity 'US Food and Drug Administration' named entity 'viral load' named entity 'Hong Kong' named entity 'pathogen inactivation' named entity 'WHO' named entity 'symptom' named entity 'SARS-CoV' named entity 'Atypical pneumonia' named entity 'coronaviruses' named entity 'infection' named entity 'genome' named entity 'Vietnam' named entity 'COVID-19' named entity 'infectivity' named entity 'visible light'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software